COVID-19 Coagulopathy

Autor: Andrew Rettew, Ian Garrahy, Shoja Rahimian, Rebecca Brown, Navdeep Sangha
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Life, Vol 14, Iss 8, p 953 (2024)
Druh dokumentu: article
ISSN: 2075-1729
DOI: 10.3390/life14080953
Popis: Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite being a primary respiratory illness, it is commonly complicated by systemic involvement of the vasculature leading to arterial and venous thrombosis. In this review, we will focus on the association between COVID-19 and thrombosis. We will highlight the pathophysiology of COVID-19 coagulopathy. The clinical manifestations of COVID-19 vasculopathy will be discussed with a focus on venous and arterial thromboembolic events. COVID-19 vasculopathy and disseminated intravascular coagulation (DIC) are distinguished within, as well as areas of controversy, such as “long COVID”. Finally, the current professional guidelines on prevention and treatment of thrombosis associated with SARS-CoV-2 infection will be discussed.
Databáze: Directory of Open Access Journals
Nepřihlášeným uživatelům se plný text nezobrazuje